Paper19213680
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Hohnloser SH and 7 others. N Engl J Med, 2009. Cited by 855 papers, by iCite.
Cite this record
ConductScience Library. Effect of dronedarone on cardiovascular events in atrial fibrillation. Papers, record 19213680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19213680
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amiodarone | Major topic |
| Anti-Arrhythmia Agents | Major topic |
| Atrial Fibrillation | Major topic |
| Aged | |
| Bradycardia | |
| Cardiovascular Diseases | |
| Creatinine | |
| Double-Blind Method | |
| Dronedarone | |
| Female | |
| Follow-Up Studies | |
| Hospitalization | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Risk Factors | |
| Secondary Prevention | |
| Treatment Outcome |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00174785 | A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation | Results | Yes | ClinicalTrials.gov |
| NCT04704050 | Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence | Background | ClinicalTrials.gov | |
| NCT05130268 | Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation | Background | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 19494229 | Dronedarone in atrial fibrillation. | https://conductscience.org/library/papers/19494229 | PubMed |
| Comment in | 19504762 | Dronedarone in atrial fibrillation. | https://conductscience.org/library/papers/19504762 | PubMed |
| Comment in | 19504766 | Dronedarone in atrial fibrillation. | https://conductscience.org/library/papers/19504766 | PubMed |
| Comment in | 19504767 | Dronedarone in atrial fibrillation. | https://conductscience.org/library/papers/19504767 | PubMed |
| Comment in | 19548374 | [The effect of dronedarone on the frequency of cardiovascular events in patients with atrial fibrillation - ATHENA studies]. | https://conductscience.org/library/papers/19548374 | PubMed |
Cited by330
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 855 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923076 | 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part III) on Rate and Rhythm Control in Atrial Fibrillation. | J Arrhythm | 2026 | https://conductscience.org/library/papers/42923076 | PubMed |
| 42796389 | Artificial Intelligence for Precision Antiarrhythmic Drug Therapy in Atrial Fibrillation: From Recurrence Prediction to Comparative Treatment Selection. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42796389 | PubMed |
| 42792664 | Atrial Fibrillation and HFrEF: Cause, Consequence, or Both? | Biomedicines | 2026 | https://conductscience.org/library/papers/42792664 | PubMed |
| 42774368 | Dronedarone vs class Ic agents for early AF: Protocol for the DRIVE-AF randomized clinical trial. | Heart Rhythm O2 | 2026 | https://conductscience.org/library/papers/42774368 | PubMed |
| 42511832 | Effects of Antiarrhythmics on Cardiac Phenotype and Redox Balance in Spontaneously Hypertensive Rats. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511832 | PubMed |
| 42374601 | Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42374601 | PubMed |
| 42048541 | Comparison of the effectiveness and safety of dronedarone and amiodarone for preventing recurrence after catheter ablation of atrial fibrillation: an open-label randomized controlled trial. | Europace | 2026 | https://conductscience.org/library/papers/42048541 | PubMed |
| 42029585 | Repurposing Coronary Risk Scores to Identify Increased Likelihood of Atrial Fibrillation in Chronic Coronary Syndrome. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42029585 | PubMed |
| 41971091 | From allergy to arrhythmia - electrophysiological basis for the antiarrhythmic properties of antazoline. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41971091 | PubMed |
| 41954064 | Long-Term Outcomes With Class 1C Antiarrhythmic Drug Use in Atrial Fibrillation. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41954064 | PubMed |
| 41865291 | Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial. | J Cardiovasc Electrophysiol | 2026 | https://conductscience.org/library/papers/41865291 | PubMed |
| 41864250 | Pharmacologic rhythm control for atrial fibrillation with dronedarone versus sotalol in patients with and without heart failure. | Curr Probl Cardiol | 2026 | https://conductscience.org/library/papers/41864250 | PubMed |
| 41848064 | Impact of Atrial Fibrillation Pattern on Edoxaban Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease: A Secondary Analysis of the EPIC-CAD Randomized Clinical Trial. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/41848064 | PubMed |
| 41845224 | Potential use of ivabradine in postoperative junctional ectopic tachycardia: a systematic review and single-arm meta-analysis. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/41845224 | PubMed |
| 41797856 | Kuwait Atrial Fibrillation Management Analysis-Insights From a Tertiary Center in Kuwait. | J Arrhythm | 2026 | https://conductscience.org/library/papers/41797856 | PubMed |
| 41757257 | Resolution of long-standing persistent atrial fibrillation after coronary revascularization: a case report on this rare reversible cause of atrial fibrillation. | Eur Heart J Case Rep | 2026 | https://conductscience.org/library/papers/41757257 | PubMed |
| 41552718 | New recommendations for rhythm control-What has changed in the 2023 ACC/AHA/ACCP/HRS and 2024 ESC guidelines for atrial fibrillation, and where does dronedarone fit in? | Am Heart J Plus | 2025 | https://conductscience.org/library/papers/41552718 | PubMed |
| 41552055 | Marked QTc Interval Prolongation Associated With Dronedarone in Paroxysmal Atrial Fibrillation and No Structural Disease. | Cureus | 2025 | https://conductscience.org/library/papers/41552055 | PubMed |
| 41524749 | Rate control or rhythm control strategies for stroke prevention in atrial fibrillation: a systematic review and network meta-analysis. | Clin Res Cardiol | 2026 | https://conductscience.org/library/papers/41524749 | PubMed |
| 41392710 | Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. | Europace | 2025 | https://conductscience.org/library/papers/41392710 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| DRONEDARONE | CHEMBL184412 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL184412 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19213680
GET https://conductscience.org/api/papers/v1/19213680/cited_by?page=2